Neural response to inflammatory challenge in major depressive disorder
Neural response to inflammatory challenge in major depressive disorder
批准号:
10612922
负责人:
Jonathan Savitz
金额:
$64.15万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-14 至 2026-04-30
关键词:
AcuteAffectAnhedoniaAttentionBehaviorBiologicalBloodBrainCharacteristicsChronicClinicalClinical assessmentsColorCommunicationDataDepressed moodDevelopmentDiagnosisDouble-Blind MethodEmotionsFailureFunctional Magnetic Resonance ImagingHeartHomeostasisHourHumanImmuneImmune systemImmunologicsImmunotherapyIn VitroIndividualInflammationInflammation MediatorsInflammatoryInflammatory ResponseInfusion proceduresInsula of ReilInterleukin-6InteroceptionInterventionKnowledgeLipopolysaccharidesMRI ScansMajor Depressive DisorderMeasuresMediatingMedicineMental DepressionMood DisordersMoodsOutcomeParticipantPathogenesisPathway interactionsPatientsPatternPersonsPlacebo ControlPlacebosProcessPsychometricsPublic HealthRandomizedRecoveryRecurrenceResearchRestRiskRoleSalineSex DifferencesSignal TransductionSleepStimulusStomachSubgroupSymptomsSystemTestingTimeTreatment FailureVisitcingulate cortexclinical predictorscytokinedepressed patientdepressive behaviordepressive symptomsearly life stressexperimental studyfollow-uphemodynamicsin vivoinflammatory markerinnovationmonocyteneuralneural circuitpatient populationpatient subsetsplacebo controlled studypleasureprimary outcomeprogramspsychologicrecurrent depressionresponsesafety assessmentsexsymptomatology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY: Chronic inflammation likely underlies the pathogenesis of major depressive disorder
(MDD) in a significant number of cases but we do not understand why these individuals get stuck in an
inflammatory state. We hypothesize that this subgroup of depressed patients has a defective homeostatic or
regulatory response to inflammatory stimuli such that appropriate, acute inflammatory responses fail to resolve,
leading to chronic inflammation which increases the risk for (a) developing depression, (b) its recurrence, and
(c) treatment failure. To test this hypothesis, we propose challenging the immune system of both MDD subjects
and healthy controls (HC) with an inflammatory stimulus (lipopolysaccharide, LPS) to induce a homeostatic
response. Specifically, 90 MDD and 90 HC participants will be randomized (2:1) to LPS (0.8ng/kg) or saline.
Serial blood draws will be obtained to quantify the pattern of inflammatory response using several inflammatory
markers. At the same time, participants will complete clinical ratings and undergo a pre- and post-LPS MRI
scan to measure how the transient inflammatory response affects the brain processing of interoceptive (bodily-
relevant) stimuli. Participants will also return one day and one week after LPS/saline infusion to complete
identical psychometric measures and blood draws. The MDD group, only, will also complete psychological
assessments once per month for 6 months in order to determine whether the acute response to LPS predicts
the clinical course of MDD. The main hypotheses are that: (1) relative to HC, the MDD group will show a
greater acute increase in inflammatory mediators but a blunted acute response of the neural circuitry mediating
interoceptive processes (insula and cingulate cortex) in the LPS vs. placebo condition. For the acute outcomes
we focus on the changes that occur at the peak of the inflammatory response, i.e. 2 hours post-infusion. (2).
Within the MDD group, LPS-associated changes in interoceptive processing and functional connectivity will be
correlated with the strength of the acute pro-inflammatory response. (3) These acute effects will be more
salient in MDD participants with chronic inflammation (baseline CRP ³3mg/L). That is, relative to the low
inflammation MDD group (CRP £1mg/L), the high inflammation MDD group will display a blunted
hemodynamic response of the insula and cingulate during internally-focused attention. In exploratory analyses
we will also examine whether there is a sex by diagnosis interaction effect on inflammatory and insular
response to LPS and whether the acute effects of LPS will relate to depressive symptoms over the 6-month
follow-up. This research is innovative and highly impactful because it will open up a new program of research
that will allow us to draw strong conclusions about the biological mechanisms underlying the failure to resolve
inflammation-related depressive behavior. This knowledge can ultimately be used to develop new brain or
immune-based treatments to jump-start the neural circuitry normally engaged by inflammatory stimuli, and to
target these interventions at specific patient populations.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s00213-022-06263-w
发表时间:
2022-12
期刊:
PSYCHOPHARMACOLOGY
影响因子:
3.4
作者:
[Savitz, Jonathan, Ford, Bart N., Kuplicki, Rayus, Khalsa, Sahib, Teague, T. Kent, Paulus, Martin P.]
通讯作者:
Paulus, Martin P.
Herpesviruses and neuropsychiatric disorders: overlooked adversaries or innocent bystanders?
疱疹病毒和神经精神疾病:被忽视的对手还是无辜的旁观者?
DOI:
10.1038/s41386-023-01674-5
发表时间:
2024
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
[Zheng,Haixia, Savitz,Jonathan]
通讯作者:
Savitz,Jonathan
DOI:
10.1038/s41398-021-01558-6
发表时间:
2021-09-07
期刊:
Translational psychiatry
影响因子:
6.8
作者:
[Zheng H, Ford BN, Kuplicki R, Burrows K, Hunt PW, Bodurka J, Kent Teague T, Irwin MR, Yolken RH, Paulus MP, Savitz J]
通讯作者:
Savitz J
Cytomegalovirus antibodies are associated with mood disorders, suicide, markers of neuroinflammation, and microglia activation in postmortem brain samples.
巨细胞病毒抗体与死后大脑样本中的情绪障碍、自杀、神经炎症标志物和小胶质细胞激活有关。
DOI:
10.1038/s41380-023-02162-4
发表时间:
2023
期刊:
Molecular psychiatry
影响因子:
11
作者:
[Zheng,Haixia, Webster,MareeJ, Weickert,CynthiaShannon, Beasley,ClareL, Paulus,MartinP, Yolken,RobertH, Savitz,Jonathan]
通讯作者:
Savitz,Jonathan
C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder.
C反应蛋白和犬尿酸与喹啉酸的比例与重度抑郁症的白质完整性独立相关。
DOI:
10.1016/j.bbi.2022.07.011
发表时间:
2022-10
期刊:
Brain, behavior, and immunity
影响因子:
--
作者:
[]
通讯作者:
共 7 条
NeuroMAP Phase II - Circuits and Molecules Core
-
批准号:10711137
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2023
-
负责人:Jonathan Savitz
-
依托单位:
Neural response to inflammatory challenge in major depressive disorder
-
批准号:10203286
-
项目类别:
-
资助金额:$75.11万
-
财政年份:2021
-
负责人:Jonathan Savitz
-
依托单位:
Neural response to inflammatory challenge in major depressive disorder
-
批准号:10405489
-
项目类别:
-
资助金额:$68.78万
-
财政年份:2021
-
负责人:Jonathan Savitz
-
依托单位:
Acute modulation of neural circuitry regulating immune function in depression
-
批准号:9752678
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2018
-
负责人:Jonathan Savitz
-
依托单位:
Neuroimaging abnormalities in major depressive disorder: effect of inflammation
-
批准号:8544495
-
项目类别:
-
资助金额:$18.14万
-
财政年份:2012
-
负责人:Jonathan Savitz
-
依托单位:
Neuroimaging abnormalities in major depressive disorder: effect of inflammation
-
批准号:8717731
-
项目类别:
-
资助金额:$18.08万
-
财政年份:2012
-
负责人:Jonathan Savitz
-
依托单位:
Neuroimaging abnormalities in major depressive disorder: effect of inflammation
-
批准号:8383235
-
项目类别:
-
资助金额:$18.2万
-
财政年份:2012
-
负责人:Jonathan Savitz
-
依托单位:
Response to inflammatory challenge in major depressive disorder
-
批准号:9210854
-
项目类别:
-
资助金额:$27.51万
-
财政年份:--
-
负责人:Jonathan Savitz
-
依托单位:
海外基金